![Darren Cline](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 452 529 $ in data 31/05/2026
Darren S.
Cline currently serves as Independent Director at Pliant Therapeutics, Inc. since 2023, Independent Director at Pyxis Oncology, Inc. since 2021, and Chief Commercial Officer at Xenon Pharmaceuticals, Inc. starting in 2025.
Former roles include President, Chief Executive Officer & Director at Epygenix Therapeutics, Inc. from 2022 to 2023; Independent Director at IPI Legacy Liquidation Co. from 2023 to 2024; Chief Commercial Officer at Greenwich Biosciences, Inc. from 2019 to 2021; Chief Commercial Officer-United States at GW Pharmaceuticals Ltd. from 2019 to 2021; Executive Vice President-Commercial at Seagen, Inc. from 2016 to 2019; Vice President-Market Access at InterMune, Inc. from 2009 to 2010; Executive Director-Sales at Alexion Pharmaceuticals, Inc. from 2006 to 2009; Marketing Director at Amgen, Inc.; and Director roles at Acadia Realty Trust, Cascadian Therapeutics LLC, and Stemline Therapeutics, Inc. Education includes undergraduate studies at San Diego State University and an MBA from Pepperdine Graziadio Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 251.405 ( 0,4% ) | 452 529 $ | 31/05/2026 | |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 09/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/09/2021 |
| PLIANT THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 06/03/2023 |
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 23/06/2025 |
| Società | Posizione | Fine |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Direttore/Membro del Consiglio | 01/04/2024 |
Epygenix Therapeutics, Inc.
 Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Amministratore Delegato | 01/03/2023 |
Greenwich Biosciences, Inc.
 Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets cannabinoid prescription medicines through online | Corporate Officer/Principal | 01/12/2021 |
| GW PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/12/2021 |
| SEAGEN INC. | Corporate Officer/Principal | 01/03/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acadia Realty Trust
 Acadia Realty Trust Real Estate Investment TrustsFinance Operates as a real estate investment trust which owns, acquires, develops and manages retail properties | Finance |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Greenwich Biosciences, Inc.
Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets cannabinoid prescription medicines through online | Health Technology |
Pepperdine Graziadio Business School
 Pepperdine Graziadio Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
